BANK ALJAZIRA-

Bank AlJazira’s net income grew 20.3% y-o-y to SAR 382.1 mn in 2Q 2025, driven by a 22% rise in total operating income, though partially offset by a 22% increase in total operating expenses, it said in a disclosure to Tadawul.

MEANWHILE- Bank AlJazira’s total income from financing grew 16.4% y-o-y to SAR 1.6 bn during the quarter, while its total income from investments fell 16.3% y-o-y to SAR 435.2 mn.

On a 1H basis, the bank’s net income was up 20.2% y-o-y at SAR 743.1 mn. Total income from financing grew 16.9% y-o-y to SAR 3.2 bn during the same period, while its total income from investments dropped 7.8% y-o-y to SAR 932.1 mn.

ALINMA BANK-

Alinma Bank reported an 11.1% y-o-y rise in net income to SAR 1.6 bn in 2Q 2025, driven by a 7.3% increase in total operating income, despite a nearly 10% rise in operating expenses, according to a disclosure to Tadawul.

The lender’s total income from financing rose 5% y-o-y to SAR 3.7 bn during the quarter, while its total income from investment increased 24.6% y-o-y to SAR 589.4 mn.

In 1H 2025, Alinma’s net income climbed 12.8% y-o-y to SAR 3.1 bn. The bank’s total income from financing increased 5.7% y-o-y to SAR 7.2 bn over the same period, while its total income from investment rose nearly 24% to SAR 1.2 bn.

Dividends on the way: Alinma Bank’s board approved distributing SAR 746.2 mn in dividends for 1H 2025 at SAR 0.30 per share, it said in a separate disclosure. The distribution date is set for 21 August.

JAMJOOM PHARMA-

Jamjoom Pharma Factory saw its net income increase 23.4% y-o-y to SAR 132 mn in 2Q 2025, according to its earningsrelease (pdf). Growth was driven by improved cost margins, strong performance across its sectors — particularly ophthalmology and dermatology — and markets, and new brand launches. Revenue grew 14.6% y-o-y to SAR 396.2 mn over the same period.

On a 1H basis, the company’s bottom line jumped 37.7% y-o-y to SAR 289.1 mn, while its revenue increased 16.8% to SAR 853.7 mn.

ALSO- Jamjoom’s board greenlit a SAR 140 mn dividend payout for 1H 2025 at SAR 2 per share, it said in a disclosure to Tadawul. The distribution date is slated for Sunday, 10 August.

Looking ahead, the company is focused on deepening its presence in existing markets, rather than expanding into new ones, CEO Tarek Hosny told Al Arabiya. He added that Jamjoom is open to acquiring pharma portfolios from other companies but is not currently looking to buy entire firms.

SADAFCO-

Saudia Dairyand Foodstuff (Sadafco) saw its net income decrease 7.9% y-o-y to SAR 117.7 mn in 2Q 2025 due to a lower gross margin and higher selling, distribution, general, and administrative expenses, it said in a disclosure to Tadawul on Thursday.

Revenue, on the other hand, rose 8.7% y-o-y to SAR 785.4 mn during the quarter, driven by a substantial 82.6% rise in Mlekoma sales, as well as maintaining the company’s market share in milk, tomato paste, and ice cream categories.

On a 1H basis, Sadafco’s bottom line was down 4% y-o-y at SAR 243.8 mn, while its top line widened 8.6% y-o-y to SAR 1.6 bn.

ELECTRICAL INDUSTRIES CO.-

ElectricalIndustries Company saw its net income jump 35.9% y-o-y to SAR 136.7 mn in 2Q 2025, spurred by sales increase and product diversification, which offset the impact of high selling and distribution expenses, it said in a Tadawul disclosure on Thursday.

Revenue grew 7.4% y-o-y to SAR 531.4 mn over the same period, backed by growing demand across all sectors, especially across high-voltage projects.

On a 1H basis, the company’s bottom line jumped 47.9% y-o-y to SAR 260.1 mn, while its top line inched up 0.1% y-o-y to SAR 1 bn.

EAST PIPES-

The East Pipes Integrated Company for Industry posted a 26.7% y-o-y rise in net income to SAR 90.3 mn in 1Q FY 2025-2026 (April through June) as sales volume went up and production costs per ton went down, it said in a disclosure to Tadawul. Revenue rose 5.7% y-o-y to SAR 385.2 mn during the same period.

Tags: